Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00187070 · ClinicalTrials.gov registry record · NA
Large Cell Lymphoma Pilot Study III
A NA study, sponsored by St. Jude Children's Research Hospital.
- Completed
- Registry status
- NA
- Development phase
- 8
- Enrollment target
NCT00187070 is a NA study that has completed, run by St. Jude Children's Research Hospital. The registered enrollment target is 8 participants.
The verdict
NCT00187070, a NA study, has completed, sponsored by St. Jude Children's Research Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 8 participants
- Enrollment target
Study Summary
The main purpose of this study is to find out if it is feasible to deliver a multi-agent chemotherapy regimen which features a shorter, more intensive, immunophenotype-directed approach, and includes an intensification phase with hematopoietic stem cell support for children with large cell lymphoma
Interventions
- RADIATION Radiation Therapy
- DRUG Doxorubicin, Cotrimoxazole, Carboplatin, Ifosfamide, Dexamethasone, Prednisone, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Vinblastine
- PROCEDURE Stem cell transplant,
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 8 participants |
| Start Date | 1997-12 |
| Est. Completion | 2001-07 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00187070
The ClinicalTrials.gov registry entry for NCT00187070 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 8 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is St. Jude Children's Research Hospital, which has 410 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Radiation Therapy is the first listed.
NCT00187070 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00187070 about?
NCT00187070 is a clinical study titled "Large Cell Lymphoma Pilot Study III". The main purpose of this study is to find out if it is feasible to deliver a multi-agent chemotherapy regimen which features a shorter, more intensive, immunophenotype-directed approach, and includes an intensification phase with hematopoietic stem cell support for children with large cell lymphoma
What is the current status of trial NCT00187070?
This trial is currently completed. It is a NA study. The enrollment target is 8 participants. The study started on 1997-12. Estimated completion is 2001-07.
What interventions are being tested in trial NCT00187070?
The interventions under investigation include: Radiation Therapy (RADIATION), Doxorubicin, Cotrimoxazole, Carboplatin, Ifosfamide, Dexamethasone, Prednisone, Vincristine, Cytarabine, Methotrexate, Etoposide, Cyclophosphamide, Vinblastine (DRUG), Stem cell transplant, (PROCEDURE).
Who is sponsoring clinical trial NCT00187070?
This trial is sponsored by St. Jude Children's Research Hospital, which has 410 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.